| Brand Name | SINGLE USE LIGATING DEVICE |
| Common Device Name | Ligator, Esophageal |
| Manufacturer (Section D) |
| AOMORI OLYMPUS CO., LTD. |
| 2-248-1 okkonoki |
| kuroishi-shi, aomori 036-0 357 |
| JA 036-0357 |
|
| Manufacturer (Section G) |
| AOMORI OLYMPUS CO., LTD. |
| 2-248-1 okkonoki |
|
| kuroishi-shi, aomori 036-0 357 |
|
JA
036-0357
|
|
| Manufacturer Contact |
|
todd
brill
|
| 800 west park drive |
| westborough, MA 01581
|
|
5082077661
|
|
| MDR Report Key | 25595142 |
| Report Number | 9614641-2026-00648 |
| Device Sequence Number | 14823229 |
| Product Code |
MND
|
| UDI-Device Identifier | 04953170194641 |
| UDI-Public | 04953170194641 |
| Combination Product (Y/N) | N |
| Initial Reporter Country | US |
| PMA/510(K) Number | CLASS2-EXMPT |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Foreign,Health Professional,User Facility |
| Initial Reporter Occupation |
Other Health Care Professional
|
| Remedial Action |
Relabeling |
| Type of Report
| Initial,Followup |
| Report Date (Section B) |
08/28/2026 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
No
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Health Professional
|
| Device Model Number | HX-400U-30 |
| Device Lot Number | V5311 53V |
| Date Returned to Manufacturer | 06/03/2026 |
| Is the Reporter a Health Professional? |
No
|
| Was the Report Sent to FDA? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 05/26/2026 |
| Supplement Date Received by Manufacturer | 08/21/2026
|
| Initial Report FDA Received Date | 06/23/2026 |
| Supplement Report FDA Received Date | 08/28/2026
|
| Was Device Evaluated by Manufacturer? (Y/N) |
Yes
|
| Date Device Manufactured | 03/11/2025 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement | 3003995201-09/30/2025-00 |
| Patient Sequence Number | 1 |
| Patient Sex | Unknown |
|
|